These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 4811225)
1. Ergot alkaloids. Ergolines and related compounds as inhibitors of prolactin release. Cassady JM; Li GS; Spitzner EB; Floss HG; Clemens JA J Med Chem; 1974 Mar; 17(3):300-7. PubMed ID: 4811225 [No Abstract] [Full Text] [Related]
2. Ergot alkaloids. Synthesis of 6-alkyl-8-ergolenes and 6-methyl-8-aminoergolines as potential prolactin inhibitors. Crider AM; Robinson JM; Floss HG; Cassady JM; Clemens JA J Med Chem; 1977 Nov; 20(11):1473-7. PubMed ID: 915908 [TBL] [Abstract][Full Text] [Related]
3. Ergot alkaloids. Synthesis of 6-methyl-8-ergolenes as inhibitors of prolactin release. Li GS; Robinson JM; Floss HG; Cassady JM J Med Chem; 1975 Sep; 18(9):892-5. PubMed ID: 1159711 [TBL] [Abstract][Full Text] [Related]
4. Ergoline congeners as potential inhibitors of prolactin release. 2. Rusterholz DB; Barfknecht CF; Clemens JA J Med Chem; 1976 Jan; 19(1):99-102. PubMed ID: 1246056 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of prolactin secretion by ergolines. Clemens JA; Shaar CJ; Smalstig EB; Bach NJ; Kornfeld EC Endocrinology; 1974 Apr; 94(4):1171-6. PubMed ID: 4818776 [No Abstract] [Full Text] [Related]
6. Reduction of serum prolactin in rats by 2 ergot alkaloids and 2 ergoline derivatives: a comparison. Brooks CL; Welsch CW Proc Soc Exp Biol Med; 1974 Jul; 146(3):863-7. PubMed ID: 4841203 [No Abstract] [Full Text] [Related]
7. Ergot alkaloids. New ergolines as selective dopaminergic stimulants. Stütz PL; Stadler PA; Vigouret JM; Jaton A J Med Chem; 1978 Aug; 21(8):754-7. PubMed ID: 567695 [TBL] [Abstract][Full Text] [Related]
8. Ergot alkaloids. Synthesis of nitrosourea derivatives of ergolines as potential anticancer agents. Crider AM; Lu CK; Floss HG; Cassady JM; Clemens JA J Med Chem; 1979 Jan; 22(1):32-5. PubMed ID: 423180 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of D-oxa tricyclic partial ergolines as dopamine agonists. Booher RN; Kornfeld EC; Smalstig EB; Clemens JA J Med Chem; 1987 Mar; 30(3):580-3. PubMed ID: 3102743 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive ergoline derivatives. Mantegani S; Temperilli A; Traquandi G; Salvati P; Di Salle E; Lamberti E; Bonsignori A Drug Des Deliv; 1987 May; 1(4):313-23. PubMed ID: 3509340 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of prolactin by ergoline congeners. Barfknecht CF; Rusterholz DB J Med Chem; 1974 Mar; 17(3):308-12. PubMed ID: 4811226 [No Abstract] [Full Text] [Related]
12. [Synthesis of glycosides and sugar orthoesters of 9,10-dihydrolysergol]. Seifert K; Johne S Arch Pharm (Weinheim); 1984 Jul; 317(7):577-83. PubMed ID: 6487053 [No Abstract] [Full Text] [Related]
13. Effect of the ergot derivative lisuride hydrogen maleate on serum prolactin concentrations in female rats. Gräf KJ; Neumann F; Horowski R Endocrinology; 1976 Mar; 98(3):598-605. PubMed ID: 1261489 [TBL] [Abstract][Full Text] [Related]
14. Descarboxylysergic acid (9,10-didehydro-6-methylergoline). Bach NJ; Hall DA; Kornfeld EC J Med Chem; 1974 Mar; 17(3):312-4. PubMed ID: 4811227 [No Abstract] [Full Text] [Related]
16. Mechanisms underlying the prolactin-lowering effect of meterogoline in the rat. Cocchi D; Locatelli V; Carminati R; Müller EE Life Sci; 1978 Sep; 23(9):927-36. PubMed ID: 703523 [No Abstract] [Full Text] [Related]
17. [Analogue drugs of ergot-alkaloids with an inhibitory effect upon prolactin secretion and their influence upon the mammary gland (author's transl)]. Rezábek K; Ausková M; Semonský M Cesk Gynekol; 1975 Feb; 40(1):52-3. PubMed ID: 1131904 [No Abstract] [Full Text] [Related]
18. Influence of apomorphine hydrochloride, dibutyryl-apomorphine and Lysenyl on plasma prolactin concentrations in the rat. Horowski R; Neumann F; Gräf KJ J Pharm Pharmacol; 1975 Jul; 27(7):532-4. PubMed ID: 239161 [No Abstract] [Full Text] [Related]